IN2013MU01151A - - Google Patents
Info
- Publication number
- IN2013MU01151A IN2013MU01151A IN1151MU2013A IN2013MU01151A IN 2013MU01151 A IN2013MU01151 A IN 2013MU01151A IN 1151MU2013 A IN1151MU2013 A IN 1151MU2013A IN 2013MU01151 A IN2013MU01151 A IN 2013MU01151A
- Authority
- IN
- India
- Prior art keywords
- mcc
- lactose
- pharmaceutical composition
- relates
- present
- Prior art date
Links
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 3
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 3
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 2
- 239000008101 lactose Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000000735 allogeneic effect Effects 0.000 abstract 1
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical group OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 abstract 1
- 229960000951 mycophenolic acid Drugs 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2014/060080 WO2014167442A1 (en) | 2013-03-26 | 2014-03-24 | Pharmaceutical compositions comprising mycophenolic acid or salts thereof |
| IN1151MU2013 IN2013MU01151A (cg-RX-API-DMAC7.html) | 2013-03-26 | 2014-03-24 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1151MU2013 IN2013MU01151A (cg-RX-API-DMAC7.html) | 2013-03-26 | 2014-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU01151A true IN2013MU01151A (cg-RX-API-DMAC7.html) | 2015-04-24 |
Family
ID=54395421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1151MU2013 IN2013MU01151A (cg-RX-API-DMAC7.html) | 2013-03-26 | 2014-03-24 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU01151A (cg-RX-API-DMAC7.html) |
-
2014
- 2014-03-24 IN IN1151MU2013 patent/IN2013MU01151A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| MX2015012414A (es) | Sal de omecamtiv mecarbilo y proceso para preparar la sal. | |
| IN2015KN00262A (cg-RX-API-DMAC7.html) | ||
| PH12017500281A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| IN2015DN00017A (cg-RX-API-DMAC7.html) | ||
| EA201491672A1 (ru) | Гетероциклильные соединения как ингибиторы mek | |
| MX348823B (es) | Formulaciones estables de linaclotida. | |
| EA201890883A1 (ru) | Вакуумная дистилляция для обогащения каннабидиола | |
| MD20140073A2 (en) | New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them | |
| MX2021011906A (es) | Composiciones de liberacion retardada de linaclotida. | |
| PH12015502539B1 (en) | Cenicriviroc compositions and methods of making and using the same | |
| MX2015004947A (es) | Sistema cristalino multicomponente que comprende nilotinib y formadores de cocristal seleccionados. | |
| EA201490395A1 (ru) | Способ получения фармацевтических композиций, содержащих финголимод | |
| EA201600434A1 (ru) | Применение производных бензимидазолпролина | |
| PH12017501133A1 (en) | Pyrazolopyridinamines | |
| PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
| MX360048B (es) | Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico. | |
| MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
| PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| MX2014009933A (es) | Diaminopirimidinas utiles como inhibidores del virus sincitial respiratorio humano (rsv). | |
| IN2013MU01151A (cg-RX-API-DMAC7.html) | ||
| MX2022005766A (es) | Compuestos y métodos para la preparación de compuestos moduladores de esfingosina 1-fosfato tipo 1 (s1p1). | |
| IN2013MU01153A (cg-RX-API-DMAC7.html) | ||
| PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
| MX2017005080A (es) | Preparacion de citrato de zinc y composiciones para cuidado oral que contienen citrato de zinc. |